Person who experienced the adverse event (patient)
Event ID | CASEID | CASEVERSION | I F COD | EVENT DT | MFR DT | INIT FDA DT | FDA DT | REPT COD | AUTH NUM | MFR NUM | MFR SNDR | LIT REF | AGE | AGE COD | AGE GRP | GNDR COD | E SUB | WT | WT COD | REPT DT | TO MFR | OCCP COD | REPORTER COUNTRY | OCCR COUNTRY |
---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|
127273391 | 12727339 | 1 | I | 20160826 | 20160909 | 20160909 | EXP | CA-APOTEX-2016AP011016 | APOTEX | 66.00 | YR | M | Y | 0.00000 | 20160909 | CN | CA | CA |
Drug(s) used by person
Event ID | CASEID | DRUG SEQ | ROLE COD | DRUGNAME | PROD AI | VAL VBM | ROUTE | DOSE VBM | CUM DOSE CHR | CUM DOSE UNIT | DECHAL | RECHAL | LOT NUM | EXP DT | NDA NUM | DOSE AMT | DOSE UNIT | DOSE FORM | DOSE FREQ |
---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|
127273391 | 12727339 | 1 | SS | APO-ESOMEPRAZOLE | ESOMEPRAZOLE | 1 | Oral | 40 MG, QD | U | U | 0 | 40 | MG | TABLET | |||||
127273391 | 12727339 | 2 | SS | APO FOLIC ACID | FOLIC ACID | 1 | Unknown | 1 DF, TWICE WEEKLY | U | U | 0 | 1 | DF | TABLET | |||||
127273391 | 12727339 | 3 | PS | GABAPENTIN. | GABAPENTIN | 1 | Unknown | UNK | U | U | 77661 | TABLET | |||||||
127273391 | 12727339 | 4 | SS | PREDNISONE. | PREDNISONE | 1 | Unknown | 5 MG, QD | U | U | 0 | 5 | MG | TABLET | |||||
127273391 | 12727339 | 5 | SS | METHOTREXATE. | METHOTREXATE | 1 | Subcutaneous | 25 MG, Q.WK. | U | U | 0 | 25 | MG | /wk | |||||
127273391 | 12727339 | 6 | SS | PLAQUENIL /00072602/ | HYDROXYCHLOROQUINE DIPHOSPHATE | 1 | Unknown | 200 MG, BID | U | U | 0 | 200 | MG | BID | |||||
127273391 | 12727339 | 7 | SS | XELJANZ | TOFACITINIB CITRATE | 1 | Oral | UNK | U | U | 0 | ||||||||
127273391 | 12727339 | 8 | SS | XELJANZ | TOFACITINIB CITRATE | 1 | Oral | 5 MG, BID | U | U | 0 | 5 | MG | BID | |||||
127273391 | 12727339 | 9 | SS | XELJANZ | TOFACITINIB CITRATE | 1 | Oral | 5 MG, QD | U | U | 0 | 5 | MG | ||||||
127273391 | 12727339 | 10 | SS | XELJANZ | TOFACITINIB CITRATE | 1 | Oral | 5 MG, BID | U | U | 0 | 5 | MG | BID |
Indications of drugs used
Event ID | CASEID | INDI DRUG SEQ | INDI PT |
---|---|---|---|
127273391 | 12727339 | 1 | Product used for unknown indication |
127273391 | 12727339 | 2 | Rheumatoid arthritis |
127273391 | 12727339 | 3 | Product used for unknown indication |
127273391 | 12727339 | 4 | Product used for unknown indication |
127273391 | 12727339 | 5 | Rheumatoid arthritis |
127273391 | 12727339 | 6 | Product used for unknown indication |
127273391 | 12727339 | 7 | Rheumatoid arthritis |
Outcome of event
Event ID | CASEID | OUTC COD |
---|---|---|
127273391 | 12727339 | OT |
127273391 | 12727339 | HO |
Reactions reported
Event ID | CASEID | DRUG REC ACT | PT |
---|---|---|---|
127273391 | 12727339 | Abdominal pain lower | |
127273391 | 12727339 | Diarrhoea | |
127273391 | 12727339 | Drug ineffective | |
127273391 | 12727339 | Fatigue | |
127273391 | 12727339 | Hernia | |
127273391 | 12727339 | Pneumonia | |
127273391 | 12727339 | Presyncope | |
127273391 | 12727339 | Rheumatoid arthritis |
Reporting Sources (this data is often not reported and may therefore be missing here)
no results found |
Therapies reported
no results found |